AP NEWS

AmeriCann CEO to Present at Science and Education Conference in Massachusetts

September 21, 2018
1 of 2

Event Focuses on Cannabis Research, Cultivation and Extraction Best Practices and StandardsDENVER, CO / ACCESSWIRE / September 21, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an Agricultural-Technology company that is developing state-of-the-art

Event Focuses on Cannabis Research, Cultivation and Extraction Best Practices and Standards

DENVER, CO / ACCESSWIRE / September 21, 2018 / AmeriCann, Inc. (OTCQB: ACAN ), an Agricultural-Technology company that is developing state-of-the-art greenhouse cannabis cultivation and processing properties, announced today that CEO Tim Keogh will be speaking at the Cannabis Community Care and Research Network’s (C3RN) Cannabis Science and Education Series on Sunday, September 23 in Boston, MA.

The event is part of C3RN’s monthly Cannabis Science, Education, and Networking series in Massachusetts to showcase the latest cannabis innovations. The events attract diverse groups of leaders from within and outside of the cannabis industry, public health and policy experts and other businesses. Mr. Keogh will be leading a discussion about best practices for cannabis cultivation and extraction.

Tim Keogh, AmeriCann CEO, has spoken at cannabis industry conferences across the United States as an expert on topics including industry best practices, real estate development and the cannabis economy. Marijuana Business Daily recognized Mr. Keogh as one of the “Top People to Watch in 2018.”

AmeriCann is developing the Massachusetts Medical Cannabis Center (MMCC), a state-of-the-art cannabis cultivation and processing development in the midst of the rapidly growing Massachusetts medical cannabis market. The MMCC project is approved for 1 million square feet, which will be developed in phases and is expected to be one of the most technologically advanced cultivation facilities in the nation.

On September 25, 2018, AmeriCann will host a ground-breaking celebration at the MMCC in Freetown at 11am. The event will celebrate the first phase of the MMCC construction which will be a 30,000 sq. ft. cannabis cultivation, processing and research facility. AmeriCann plans to complete the first phase of the MMCC by the spring of 2019.

About Massachusetts Medical Cannabis Center

Massachusetts Medical Cannabis Center (MMCC) has been approved for a one million square foot sustainable greenhouse facility in Freetown, Mass. The first phase of the facility is scheduled to open and be ready for cannabis cultivation, processing, and infused product production in the spring of 2019. Once fully developed, the MMCC design calls for a research facility, a training center, corporate offices, a quality-assurance laboratory, and a facility for manufacturing cannabis-infused food, nutraceuticals and consumer packaged cannabis goods. AmeriCann intends to open similar facilities in states in which cannabis is legal for medical and adult use.

About AmeriCann

AmeriCann (OTCQB: ACAN ) is a publicly traded agricultural technology (Ag-Tech) company that is developing a new generation of sustainable, state-of-the-art medical cannabis cultivation and processing properties.

AmeriCann, Inc. is a Certified B Corp, an acknowledgment of the Company’s commitment to social and environmental ethics, transparency and accountability. AmeriCann became the first public cannabis company to earn this respected accreditation. More information about the Company is available at: www.americann.co, or follow AmeriCann on Twitter @ACANinfo.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Registration Statement on Form S-1, which the Company recently filed with the SEC and which may be viewed at www.sec.gov.

Contact Information:

Corporate:

AmeriCann, Inc.

1550 Wewatta Street

2nd Floor

Denver, CO 80202

(303) 862-9000

www.americann.co

@ACANinfo on Twitter

Media:

Teak Media + Communication

Stacy Wilbur

617-269-7171

Investors:

Hayden IR

(917) 658-7878

SOURCE: AmeriCann, Inc.

https://www.accesswire.com/512341/AmeriCann-CEO-to-Present-at-Science-and-Education-Conference-in-Massachusetts
AP RADIO
Update hourly